Jubilant Biosys partners with pharmaceutical and biotechnology companies to translate laboratory-scale processes into robust, scalable manufacturing solutions for high-value intermediates and APIs. Our scale-up expertise ensures consistent performance, optimized yields, and controlled impurity profiles across development stages. With a strong focus on process understanding, safety, and reproducibility, we enable seamless progression from early development to pilot and commercial scale. Backed by an integrated R&D and scale-up ecosystem, we support smooth transition from discovery to gram-to-kilogram scale production, enabling faster and more reliable process scale-up. Capabilities * Process development, optimization, and control strategy * Lab-to-pilot and pilot-to-commercial scale-up * Technology transfer and manufacturing readiness * Scale-up from grams to ~25 kg using reactors ranging from 20L to 250L * Robust infrastructure supporting multi-step small-molecule synthesis and early-phase scale-up Key Strengths * Integrated discovery-to-scale-up platform enabling seamless progression across stages * Strong expertise in route scouting, process optimization, and scalable chemistry development * Risk-assessed scale-up supported by structured safety evaluation frameworks * Operations aligned with global quality and safety standards with SOP-driven execution * Flexible collaboration models supporting both FFS and FTE engagements
Compiled from https://www.jubilantbiosys.com
